Your browser doesn't support javascript.
loading
Cardiovascular Mortality during the COVID-19 Pandemics in a Large Brazilian City: a Comprehensive Analysis
Luisa Campos Caldeira Brant; Pedro C Pinheiro; Antonio L P Ribeiro; Isis E Machado; Paulo R L Correa; Mayara R Santos; Maria de Fatima M de Souza; Deborah C Malta; Valeria M A Passos.
Affiliation
  • Luisa Campos Caldeira Brant; School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
  • Pedro C Pinheiro; School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
  • Antonio L P Ribeiro; School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
  • Isis E Machado; Municipal Health Secretariat, Belo Horizonte, MG, Brazil
  • Paulo R L Correa; School of Medicine, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil
  • Mayara R Santos; School of Medicine, Universidade Federal de Ouro Preto, Ouro Preto, MG, Brazil
  • Maria de Fatima M de Souza; Vital Strategies, Sao Paulo, SP, Brazil
  • Deborah C Malta; Nursing School, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
  • Valeria M A Passos; School of Medicine, Universidade Federal de Minas Gerais, Belo Horizonte, MG, Brazil
Preprint in English | medRxiv | ID: ppmedrxiv-21264699
ABSTRACT
IntroductionThe impact of COVID-19 pandemics on cardiovascular diseases (CVD) may be caused by health system reorganization and/or collapse, or from changes in the behaviour of individuals. In Brazil, municipalities were empowered to define regulatory measures, potentially resulting in diverse effects on CVD morbimortality. ObjectiveTo analyse the impact of COVID-19 pandemics on CVD outcomes in Belo Horizonte (BH), the 6th greater capital city in Brazil, including mortality, mortality at home, hospitalizations, intensive care unit utilization, and in-hospital mortality; and the differential effect according to sex, age range, social vulnerability, and pandemics phase. MethodsEcological study analysing data from the Mortality and Hospital Information System of BH residents aged [≥]30 years. CVD was defined as in Chapter IX from ICD-10. Social vulnerability was classified by a composite socioeconomic index as high, medium and low. The observed age-standardized rates for epidemiological weeks 10-48, 2020, were compared to the expected rates (mean of 2015-2019). Wilcoxon rank-sum test was used to test differences, and risk ratios with their 95% confidence intervals were calculated. National demographic estimates was used to calculate rates. ResultsWe found no changes in CVD mortality rates (RiR 1.01, 95%CI 0.96-1.06). However, CVD deaths occurred more at homes (RiR 1.32, 95%CI 1.20-1.46) than in hospitals (RiR 0.89, 95%CI 0.79-0.99), as a result of a substantial decline in hospitalization rates, even though proportional in-hospital deaths increased. The rise in home deaths was greater in older adults and in had an increasing gradient in those more socially vulnerable (RiR 1.45); for high (RiR 1.45), medium (RiR 1.32) and low vulnerability (RiR 1.21). ConclusionThe greater occurrence of CVD deaths at home, in parallel with lower hospitalization rates, suggests that CVD care was disrupted during the COVID-19 pandemics, which more adversely affected older and more socially vulnerable individuals, exacerbating health inequities in BH.
License
cc_by_nc_nd
Full text: Available Collection: Preprints Database: medRxiv Type of study: Prognostic study Language: English Year: 2021 Document type: Preprint
Full text: Available Collection: Preprints Database: medRxiv Type of study: Prognostic study Language: English Year: 2021 Document type: Preprint
...